Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
AZ Looks To Lead Severe Asthma Market After US Fasenra OK
Nov 15 2017
•
By
Kevin Grogan
AstraZeneca joins the severe asthma race with the US approval of Fasenra • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Respiratory
More from Therapeutic Category